AIDS/IAS Conference
Conference Coverage
Neural tube defect risk from dolutegravir drops as clinical experience grows
A troubling link between the top HIV drug dolutegravir and neural tube defects, first reported in 2018, now seems much less dangerous.
Conference Coverage
HIV does not appear to worsen COVID-19 outcomes
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD.
Conference Coverage
Antiretroviral-eluting implant could provide HIV prophylaxis for a year or more
The long-term islatravir implant could one day provide an easier adherence alternative for many.
Conference Coverage
New WHO recommendations promote dolutegravir benefits in the face of lowered risk signal for neural tube defects
Conference Coverage
On-demand and daily PrEP look similar for HIV prevention
Prospective study of more than 1,100 French MSM showed on-demand PrEP performed as well as daily PrEP for preventing HIV infection.
Conference Coverage
People with HIV develop more frailty despite treatment
AMSTERDAM – Middle-aged and elderly people with HIV developed more frailty than did similar uninfected people, and frailty predicted worse...
Video
Incident heart failure linked to HIV infection
AMSTERDAM – Medical records from a large U.S. health system suggest that incident heart failure independently links to HIV infection.
Conference Coverage
HIV infection linked with doubled stroke rate
AMSTERDAM – Data from more than 22 million Taiwan residents showed HIV-infected patients had a doubled stroke rate compared with the general...
Conference Coverage
Oral prophylaxis and vaginal ring effective in adolescent HIV prevention
Trials show two new possible solutions for HIV prevention in adolescent girls.
Conference Coverage
South African child has suppressed HIV without ART since infancy
The first case of sustained HIV control in a child enrolled in a randomized trial of antiretroviral therapy interruption after treatment early in...
Conference Coverage
Reassuring findings on neurodevelopmental outcomes in HIV-exposed children
DURBAN, SOUTH AFRICA – In-utero exposure to maternal HIV and antiretroviral drugs in uninfected children had no measurable adverse...
Conference Coverage
Prospects brighten for an HIV vaccine
DURBAN, SOUTH AFRICA – A palpable new optimism surrounds the possibility of creating a safe and effective vaccine for prevention of HIV infection...
Conference Coverage
Oral HIV PrEP also protects against herpes
Oral antiretroviral pre-exposure prophylaxis (PrEP) against HIV also reduces the risk of acquiring herpes simplex virus type 2, according to...
Conference Coverage
Postpartum HIV treatment reduces key maternal illnesses
DURBAN, SOUTH AFRICA – HIV-infected women who remained on antiretroviral therapy throughout the postpartum period reduced their risk of clinical...